DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
1 hedge funds and large institutions have $0 invested in DarioHealth Corp. Warrant in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $2K → $0 (-$2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$671 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| – | -$1K | -11,640 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$671 | -6,635 | -98% |
|
DRIOW Hedge Fund Activity: Q3 2020 in Review
1 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q3 2020, worth a combined $0 — down 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DRIOW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $1K sold.
- 1 institutional investor held DarioHealth Corp. Warrant (DRIOW) as of Q3 2020, down from 2 in Q2 2020.
- Funds reported $0 of DarioHealth Corp. Warrant stock for Q3 2020, down 100% quarter-over-quarter.
- 0 funds opened new DarioHealth Corp. Warrant positions in Q3 2020 and 1 closed out, a net change of -1 holder.
- The largest DarioHealth Corp. Warrant seller in Q3 2020 was Virtu Financial, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2020.